BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 9544497)

  • 1. Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test).
    Fille M; Larcher C; Dierich MP; Allerberger F
    Z Gastroenterol; 1998 Feb; 36(2):143-9. PubMed ID: 9544497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
    Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a commercial latex agglutination assay for screening for Clostridium difficile-associated disease.
    Stella PA
    Clin Lab Sci; 1994; 7(5):311-3. PubMed ID: 10150387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A.
    Gilligan PH; Walden TP; Kelly WF; Wait KJ; Kraft JA; Willis DH
    Arch Pathol Lab Med; 1993 May; 117(5):507-10. PubMed ID: 8489340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens.
    Vanpoucke H; De Baere T; Claeys G; Vaneechoutte M; Verschraegen G
    Clin Microbiol Infect; 2001 Feb; 7(2):55-64. PubMed ID: 11298143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease.
    Lee SD; Turgeon DK; Ko CW; Fritsche TR; Surawicz CM
    Am J Gastroenterol; 2003 Jul; 98(7):1569-72. PubMed ID: 12873579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
    Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
    Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea.
    O'Connor D; Hynes P; Cormican M; Collins E; Corbett-Feeney G; Cassidy M
    J Clin Microbiol; 2001 Aug; 39(8):2846-9. PubMed ID: 11474001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of a rapid latex test for the detection of Clostridium difficile in fecal specimens.
    Ryan RW; Kwasnik I; Clout D; Tilton RC
    Ann Clin Lab Sci; 1987; 17(4):232-5. PubMed ID: 3619398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea.
    Massey V; Gregson DB; Chagla AH; Storey M; John MA; Hussain Z
    Am J Clin Pathol; 2003 Jan; 119(1):45-9. PubMed ID: 12520696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
    Shin BM; Lee EJ; Kuak EY; Yoo SJ
    Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.
    Landry ML; Topal J; Ferguson D; Giudetti D; Tang Y
    J Clin Microbiol; 2001 May; 39(5):1855-8. PubMed ID: 11326003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of five commercial tests for the rapid diagnosis of Clostridium difficile-associated disease.
    Miendje Deyi VY; Vandenberg O; Mascart G; Gning S; Retore P; Douat N; Dediste A
    Clin Lab; 2008; 54(1-2):9-13. PubMed ID: 18510038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antibiotic-associated diarrhea with a latex agglutination test and cell culture cytotoxicity assay for Clostridium difficile.
    Biddle WL; Harms JL; Greenberger NJ; Miner PB
    Am J Gastroenterol; 1989 Apr; 84(4):379-82. PubMed ID: 2929558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of value of repeat stool testing for Clostridium difficile toxin.
    Mohan SS; McDermott BP; Parchuri S; Cunha BA
    Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of different methods for detection of Clostridium difficile toxins in Poland.
    Martirosian G; Pituch H; Obuch-Woszczatyński P; Rouyan G; Meisel-Mikołajczyk F
    Acta Microbiol Pol; 1999; 48(4):349-53. PubMed ID: 10756719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the latex agglutination test for detection of Clostridium difficile.
    Kelly WF; Wait KJ; Gilligan PH
    Arch Pathol Lab Med; 1992 May; 116(5):517-20. PubMed ID: 1580756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].
    Sednaoui P; el Mantih B; Cauwell M
    Pathol Biol (Paris); 1999 May; 47(5):415-21. PubMed ID: 10418011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.
    Chan EL; Seales D; Drum H
    Clin Lab Sci; 2009; 22(2):81-5. PubMed ID: 19534439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].
    Rozkiewicz D; Zaremba ML; Fiedoruk K; Daniluk T; Sciepuk M; Kurzatkowska B; Sulik A; Ołdak E
    Przegl Epidemiol; 2005; 59(3):711-21. PubMed ID: 16433313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.